Novavax Cash Conversion Cycle | NVAX

Annual Cash Conversion Cycle Novavax

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-79.7	-2.9	-73.3	-10.8	114	103	-	-	-	21	-3.32	-188	-145	-37.5	-43.4	28.7	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
114	-188	-24.4

Quarterly Cash Conversion Cycle Novavax

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	79.5	-140	-173	-	-21.5	-	-	-	82.2	-71.7	-252	-	-1.22	138	-380	-	32	16.4	32.5	-	152	673	3.64 K	77.6	273	204	85.9	-	-	-	-	-	-	-	1.87	6.96	13.5	14	29.5	36.2	32.4	15.1	45.4	102	83.4	83	57.6	19.9	36.3	49.4	34.8	20.2	16	13	29.2	30.7	35.8	59.8	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.64 K	-380	121

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AnaptysBio ANAB	205	$ 51.0	1.83 %	$ 1.48 B	USA
Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	5.06	-	-	$ 401 M	USA
BioMarin Pharmaceutical BMRN	733	$ 60.26	0.06 %	$ 11.6 B	USA
Genocea Biosciences GNCA	24.9	-	-15.0 %	$ 3.04 M	USA
Catalyst Biosciences CBIO	285	$ 13.99	0.84 %	$ 1.25 B	USA
C4 Therapeutics CCCC	27.9	$ 2.98	0.3 %	$ 247 M	USA
Codexis CDXS	-15.2	$ 1.32	1.09 %	$ 115 M	USA
Cerus Corporation CERS	47	$ 2.62	0.38 %	$ 499 M	USA
G1 Therapeutics GTHX	52.6	-	-	$ 370 M	USA
Coherus BioSciences CHRS	149	$ 1.13	0.43 %	$ 132 M	USA
Celldex Therapeutics CLDX	-3.74 K	$ 31.1	1.16 %	$ 2.07 B	USA
CollPlant Biotechnologies Ltd. CLGN	-90.5	$ 4.25	3.16 %	$ 51.9 M	Israel
AbbVie ABBV	284	$ 264.34	0.09 %	$ 468 B	USA
Humanigen HGEN	598	-	-81.12 %	$ 4.28 M	USA
Cocrystal Pharma COCP	51.2	$ 1.17	1.74 %	$ 13.2 M	USA
AbCellera Biologics ABCL	173	$ 12.7	0.4 %	$ 3.79 B	Canada
Abeona Therapeutics ABEO	-695	$ 5.4	2.65 %	$ 286 M	USA
Collegium Pharmaceutical COLL	537	$ 22.53	0.2 %	$ 713 M	USA
Corcept Therapeutics Incorporated CORT	-402	$ 116.1	4.93 %	$ 12.1 B	USA
Фармсинтез LIFE	-15.9	-	-	-	Russia
Cardiff Oncology CRDF	294	$ 1.24	0.74 %	$ 82.9 M	USA
Karuna Therapeutics KRTX	15.9	-	-	$ 12.2 B	USA
Curis CRIS	64.7	$ 0.83	1.1 %	$ 10.9 M	USA
CorMedix CRMD	359	$ 7.85	1.03 %	$ 565 K	USA
Crinetics Pharmaceuticals CRNX	-4.27 K	$ 84.95	0.13 %	$ 7.99 B	USA
CRISPR Therapeutics AG CRSP	1.3 K	$ 54.23	0.23 %	$ 4.88 B	Schweiz
Champions Oncology CSBR	9.02	$ 4.9	0.1 %	$ 67.8 M	USA
Chimerix CMRX	52.5	-	-	$ 756 M	USA
Cue Biopharma CUE	43.1	$ 31.41	1.45 %	$ 2.98 B	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.85	0.2 %	$ 929 M	Canada
Cytokinetics, Incorporated CYTK	71.3	$ 64.66	0.17 %	$ 7.77 M	USA
Daré Bioscience DARE	-1.64 K	$ 0.78	4.73 %	$ 8.72 M	USA
Adagene ADAG	58.9	$ 2.93	2.86 %	$ 173 M	China